Following the safety announcements , there was a reduction in the number of allopurinol users in the first year of intervention ( -95.82 users per 100000 persons , 95 % CI , [ -166.84 , -24.80 ] ) and a continuous reduction afterward at a rate of -53.17 per 100000 persons per year .